The role of TIM-containing molecules in airway disease and their potential as therapeutic targets

Journal of Inflammation Research

Volumn 5, Issue 1, 2012, Pages 77-87

  Vega Carrascal, Isabel ^a   Reeves, Emer P ^a   McElvaney, Noel G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Airway disease; Galectin 9; Inflammation; T cell immunoglobulin and mucin domain

Indexed keywords

ECALECTIN; KIDNEY INJURY MOLECULE 1; MEMBRANE PROTEIN; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING MOLECULE; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING PROTEIN 2; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING PROTEIN 3; UNCLASSIFIED DRUG;

HUMAN; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW;

EID: 84866029373     PISSN: None     EISSN: 11787031     Source Type: Journal    
DOI: 10.2147/JIR.S34225     Document Type: Review

References (95)

1. Wang Y, Meng J, Wang X, et al. Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand J Immunol. 2008;67(1):63-70.
2. Kuchroo VK, Dardalhon V, Xiao S, Anderson AC. New roles for TIM family members in immune regulation. Nat Rev Immunol. 2008;8(8): 577-580.
3. Su E W, Lin J Y, Kane L P. TIM-1 and TIM-3 proteins in immune regulation. Cytokine. 2008;44(1):9-13.
4. Rodriguez-Manzanet R, DeKruyff R, Kuchroo VK, Umetsu DT. The costimulatory role of TIM molecules. Immunol Rev. 2009;229(1): 259-270.
5. Recalcati S, Invernizzi P, Arosio P, Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun. 2008;30(1-2):84-89.
6. Seki M, Oomizu S, Sakata KM, et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol. 2008; 127(1):78-88.
7. Rennert PD, Ichimura T, Sizing ID, et al. T cell, Ig domain, mucin domain-2 gene-deficient mice reveal a novel mechanism for the regulation of Th2 immune responses and airway inflammation. J Immunol. 2006;177(7):4311-4321.
8. Khademi M, Illés Z, Gielen AW, et al. T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol. 2004; 172(11):7169-7176.
9. Sánchez-Fueyo A, Tian J, Picarella D, et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol. 2003;4(11):1093-1101.
10. Ngiow S F, von Scheidt B, Akiba H, Yagita H, Teng M W, Smyth MJ. Anti-TIM3 antibody promotes T cell IFN-γ-mediated antitumor immunity and suppresses established tumors. Cancer Res. 2011;71(10): 3540-3551.
11. Sakuishi K, Jayaraman P, Behar SM, Anderson AC, Kuchroo VK. Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol. 2011;32(8):345-349.
12. Jayaraman P, Sada-Ovalle I, Beladi S, et al. Tim3 binding to galectin-9 stimulates antimicrobial immunity. J Exp Med. 2010;207(11): 2343-2354.
13. ® [database on the Internet]. Bethesda, MD: National Library of Medicine; nd. Available from: http://www.ncbi.nlm.nih. gov/pubmed/. Accessed July 18, 2012.
14. Google Scholar [web search engine on the Internet]. Moutain View, CA: Google; nd. Available from: http://www.scholar.google.com. Accessed July 18, 2012.
15. The Cochrane Library [database on the Internet]. Hoboken, NJ: John Wiley and Sons; 2012. Available from: http://www.thecochranelibrary. com/view/0/index.html. Accessed July 18, 2012.
16. Meyers JH, Sabatos CA, Chakravarti S, Kuchroo VK. The TIM gene family regulates autoimmune and allergic diseases. Trends Mol Med. 2005;11(8):362-369.
17. Santiago C, Ballesteros A, Tami C, Martínez-Muñoz L, Kaplan GG, Casasnovas JM. Structures of T Cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family. Immunity. 2007;26(3):299-310.
18. Kaplan G, Totsuka A, Thompson P, Akatsuka T, Moritsugu Y, Feinstone SM. Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J. 1996;15(16):4282-4296.
19. Feigelstock D, Thompson P, Mattoo P, Zhang Y, Kaplan GG. The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J Virol. 1998;72(8):6621-6628.
20. Ichimura T, Bonventre J V, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273(7):4135-4142.
21. Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre J V. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem. 2002;277(42):39739-39748.
22. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre J V. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237-244.
23. Encinas JA, Janssen EM, Weiner DB, et al. Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma. J Allergy Clin Immunol. 2005;116(6): 1343-1349.
24. Knickelbein JE, de Souza AJ, Tosti R, Narayan P, Kane L P. Cutting edge: inhibition of T cell activation by TIM-2. J Immunol. 2006;177(8): 4966-4970.
25. Kobayashi N, Karisola P, Peña-Cruz V, et al. TIM-1 and TIM-4 glyco-proteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity. 2007;27(6):927-940.
26. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature. 2007; 450(7168):435-439.
27. Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev. 2010;235(1): 172-189.
28. van de Weyer PS, Muehlfeit M, Klose C, Bonventre J V, Walz G, Kuehn E W. A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem Biophys Res Commun. 2006;351(2):571-576.
29. Lee J, Su E W, Zhu C, et al. Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signalling pathways. Mol Cell Biol. 2011;31(19):3963-3974.
30. Zhu C, Anderson AC, Schubart A, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005; 6(12):1245-1252.
31. Monney L, Sabatos CA, Gaglia JL, et al. Th1-specifc cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 2002;415(6871):536-541.
32. Hastings WD, Anderson DE, Kassam N, et al. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol. 2009;39(9):2492-2501.
33. Sabatos CA, Chakravarti S, Cha E, et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol. 2003;4(11):1102-1110.
34. Oikawa T, Kamimura Y, Akiba H, et al. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease. J Immunol. 2006;177(7):4281-4287.
35. Nakayama M, Akiba H, Takeda K, et al. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood. 2009;113(16): 3821-3830.
36. Zhao J, Lei Z, Liu Y, et al. Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity. J Immunol. 2009;182(10): 6618-6624.
37. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffeld JS, Bonventre J V. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest. 2008;118(5):1657-1668.
38. Rabinovich GA, Liu FT, Hirashima M, Anderson A. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol. 2007;66(2-3):143-158.
39. Paroutaud P, Levi G, Teichberg VI, Strosberg AD. Extensive amino acid sequence homologies between animal lectins. Proc Natl Acad Sci U S A. 1987;84(18):6345-6348.
40. Cummings RD, Liu FT. Galectins. In: Varki A, Cummings RD, Esko JD, et al, editors. Essentials of Glycobiology [book on the Internet]. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbour Laboratory Press, 2009. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1944/. Accessed July 18, 2012.
41. Chabot S, Kashio Y, Seki M, et al. Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology. 2002;12(2): 111-118.
42. Nishi N, Itoh A, Fujiyama A, et al. Development of highly stable galectins: truncation of the linker peptide confers protease- resistance on tandem-repeat type galectins. FEBS Lett. 2005;579(10): 2058-2064.
43. Matsushita N, Nishi N, Seki M, et al. Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. J Biol Chem. 2000;275(12):8355-8360.
44. Wada J, Kanwar YS. Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J Biol Chem. 1997;272(9):6078-6086.
45. Matsumoto R, Matsumoto H, Seki M, et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem. 1998;273(27):16976-16984.
46. Shimizu Y, Kabir-Salmani M, Azadbakht M, Sugihara K, Sakai K, Iwashita M. Expression and localization of galectin-9 in the human uterodome. Endocr J. 2008;55(5):879-887.
47. Liang M, Ueno M, Oomizu S, et al. Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma. J Cancer Res Clin Oncol. 2008;134(8):899-907.
48. Pielage JF, Cichon C, Greune L, Hirashima M, Kucharzik T, Schmidt MA. Reversible differentiation of Caco-2 cells reveals galectin-9 as a surface marker molecule for human follicle-associated epithelia and M cell-like cells. Int J Biochem Cell Biol. 2007;39(10):1886-1901.
49. Park WS, Jung WK, Park SK, et al. Expression of galectin-9 by IFN-γ stimulated human nasal polyp fibroblasts through MAPK, PI3K, and JAK/STAT signaling pathways. Biochem Biophys Res Commun. 2011;411(2):259-264.
50. Kasamatsu A, Uzawa K, Shimada K, et al. Elevation of galectin-9 as an infammatory response in the periodontal ligament cells exposed to Porphylomonas gingivalis lipopolysaccharide in vitro and in vivo. Int J Biochem Cell Biol. 2005;37(2):397-408.
51. Pioche-Durieu C, Keryer C, Souquère S, et al. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin. J Virol. 2005;79(21): 13326-13337.
52. Ishikawa A, Imaizumi T, Yoshida H, et al. Double-stranded RNA enhances the expression of galectin-9 in vascular endothelial cells. Immunol Cell Biol. 2004;82(4):410-414.
53. Imaizumi T, Kumagai M, Sasaki N, et al. Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol. 2002;72(3):486-491.
54. Wiener Z, Kohalmi B, Pocza P, et al. TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells. J Invest Dermatol. 2007;127(4):906-914.
55. Spitzenberger F, Graessler J, Schroeder HE. Molecular and functional characterization of galectin 9 mRNA isoforms in porcine and human cells and tissues. Biochimie. 2001;83(9):851-862.
56. Mengshol JA, Golden-Mason L, Arikawa T, et al. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS One. 2010;5(3):e9504.
57. Stancic M, van Horssen J, Thijssen VL, et al. Increased expression of distinct galectins in multiple sclerosis lesions. Neuropathol Appl Neurobiol. 2011;37(6):654-671.
58. Yoshida H, Imaizumi T, Kumagai M, et al. Interleukin-1beta stimulates galectin-9 expression in human astrocytes. Neuroreport. 2001;12(17): 3755-3758.
59. Dietz AB, Bulur PA, Knutson GJ, Matasic R, Vuk-Pavlovic S. Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. Biochem Biophys Res Commun. 2000;275(3): 731-738.
60. Elahi S, Dinges WL, Lejarcegui N, et al. Protective HIV-specific CD8+ T cells evade Treg cell suppression. Nat Med. 2011;17(8): 989-995.
61. Sziksz E, Kozma GT, Pállinger E, et al. Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. Int Arch Allergy Immunol. 2010;151(4):308-317.
62. Abedin MJ, Kashio Y, Seki M, Nakamura K, Hirashima M. Potential roles of galectins in myeloid differentiation into three different lineages. J Leukoc Biol. 2003;73(5):650-656.
63. Saita N, Goto E, Yamamoto T, et al. Association of galectin-9 with eosinophil apoptosis. Int Arch Allergy Immunol. 2002;128(1):42-50.
64. Toscano MA, Ilarregui JM, Bianco GA, et al. Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity? Cytokine Growth Factor Rev. 2007;18(1-2): 57-71.
65. Anderson AC, Anderson DE, Bregoli L, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science. 2007;318(5853):1141-1143.
66. Zhu C, Anderson AC, Kuchroo VK. TIM-3 and its regulatory role in immune responses. Curr Top Microbiol Immunol. 2011;350:1-15.
67. Katoh S, Ishii N, Nobumoto A, et al. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med. 2007;176(1):27-35.
68. Nobumoto A, Nagahara K, Oomizu S, et al. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices. Glycobiology. 2008;18(9):735-744.
69. Niki T, Tsutsui S, Hirose S, et al. Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J Biol Chem. 2009;284(47):32344-32352.
70. Ohtsubo K, Takamatsu S, Minowa MT, Yoshida A, Takeuchi M, Marth JD. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell. 2005;123(7):1307-1321.
71. McIntire JJ, Umetsu SE, Akbari O, et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol. 2001;2(12):1109-1116.
72. Barlow JL, Wong SH, Ballantyne SJ, Jolin HE, McKenzie AN. Tim1 and Tim3 are not essential for experimental allergic asthma. Clin Exp Allerg y. 2011;41(7):1012-1021.
73. Xu G, Cheng L, Lu L, et al. Expression of T-cell immunoglobulin-and mucin-domain-containing molecule-1 (TIM-1) is increased in a mouse model of asthma and relationship to GATA-3. Life Sci. 2008; 82(11-12):663-669.
74. Umetsu SE, Lee WL, McIntire JJ, et al. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol. 2005;6(5):447-454.
75. Sizing ID, Bailly V, McCoon P, et al. Epitope-dependent effect of anti-murine TIM-1 monoclonal antibodies on T cell activity and lung immune responses. J Immunol. 2007;178(4):2249-2261.
76. Sonar SS, Hsu YM, Conrad ML, et al. Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma. J Clin Invest. 2010;120(8):2767-2781.
77. Idali F, Wahlström J, Dahlberg B, et al. Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis. Respir Res. 2009;10:42.
78. Kim HS, Kim HS, Lee CW, Chung DH. T cell Ig domain and mucin domain 1 engagement on invariant NKT cells in the presence of TCR stimulation enhances IL-4 production but inhibits IFN-gamma production. J Immunol. 2010;184(8):4095-4106.
79. Kumanogoh A, Marukawa S, Suzuki K, et al. Class IV semaphorin Sema4 A enhances T-cell activation and interacts with Tim-2. Nature. 2002;419(6907):629-633.
80. Takamatsu H, Okuno T, Kumanogoh A. Regulation of immune cell responses by semaphorins and their receptors. Cell Mol Immunol. 2010; 7(2):83-88.
81. Chen TT, Li L, Chung DH, et al. TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J Exp Med. 2005;202(7):955-965.
82. Todorich B, Zhang X, Slagle-Webb B, Seaman WE, Connor JR. Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem. 2008;107(6):1495-1505.
83. Morikawa K, Oseko F, Morikawa S. A role for ferritin in hematopoiesis and the immune system. Leuk Lymphoma. 1995;18(6):429-433.
84. Stites S W, Plautz M W, Bailey K, O'Brien-Ladner AR, Wesselius LJ. Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fbrosis. Am J Respir Crit Care Med. 1999;160(3):796-801.
85. Chakravarti S, Sabatos CA, Xiao S, et al. Tim-2 regulates T helper type 2 responses and autoimmunity. J Exp Med. 2005;202(3):437-444.
86. Kearley J, McMillan SJ, Lloyd CM. Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo. J Exp Med. 2007;204(6):1289-1294.
87. Hu WK, Lu XX, Yang S, et al. Expression of the Th1-specifc cell-surface protein Tim-3 increases in a murine model of atopic asthma. J Asthma. 2009;46(9):872-877.
88. DeKruyff RH, Bu X, Ballesteros A, et al. T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol. 2010;184(4): 1918-1930.
89. Wang F, Xu J, Liao Y, et al. Tim-3 ligand galectin-9 reduces IL-17 level and accelerates Klebsiella pneumoniae infection. Cell Immunol. 2011;269(1):22-28.
90. Sharma S, Sundararajan A, Suryawanshi A, et al. T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc Natl Acad Sci U S A. 2011;108(47):19001-19006.
91. Vega-Carrascal I, Reeves E P, Niki T, et al. Dysregulation of TIM-3-galectin-9 pathway in the cystic fibrosis airways. J Immunol. 2011; 186(5):2897-2909.
92. Yamamoto H, Kashio Y, Shoji H, et al. Involvement of galectin-9 in guinea pig allergic airway inflammation. Int Arch Allergy Immunol. 2007;143 Suppl 1:95-105.
93. Katoh S, Nobumoto A, Matsumoto N, et al. Involvement of galectin-9 in lung eosinophilia in patients with eosinophilic pneumonia. Int Arch Allergy Immunol. 2010;153(3):294-302.
94. Kojima K, Arikawa T, Saita N, et al. Galectin-9 attenuates acute lung injury by expanding CD14-plasmacytoid dendritic cell-like macrophages. Am J Respir Crit Care Med. 2011;184(3):328-339.
95. Kadowaki T, Arikawa T, Shinonaga R, et al. Galectin-9 signaling prolongs survival in murine lung-cancer by inducing macrophages to differentiate into plasmacytoid dendritic cell-like macrophages. Clin Immunol. 2012;142(3):296-307.